News

Lucy Therapeutics Receives $4.9 Million Grant from Michael J. Fox Foundation

Apr 11, 2022

CAMBRIDGE, Mass. — April 11, 2022 — Lucy Therapeutics (LucyTx), a biotech with a unifying mitochondrial platform, today announced it secured funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), the largest nonprofit funder of Parkinson’s disease research. The grant, valued at $4.9 million, will be used for continued investment into LucyTx’s mitochondrial platform, including the development of potential novel medicines.

← Prev Next →

The latest from our portfolio companies that are changing the world.

More News

Agility Robotics Opening RoboFab: World’s First Factory for Humanoid Robots

09.18.23 | AI / IT / Robotics

CORVALLIS, Ore.--(BUSINESS WIRE)--Agility Robotics, creator of the groundbreaking bipedal robot Digit, today revealed that the company is opening RoboFab™, a robot manufacturing facility in Salem, Oregon with the capability to produce more than 10,000 robots per year....

Embr Labs and UMass Amherst Develop Technology that Can Predict Hot Flashes

09.13.23 | Life Sciences

BOSTON, Sept. 13, 2023 /PRNewswire/ -- Boston-based technology startup Embr Labs is announcing the next stage of development for the Embr Wave: a consumer wearable that utilizes temperature sensations as haptic therapy. Together with researchers at the University of...

Safar Partners is committed to funding technological advances that create value.

Interested in partnering with us?

Contact Information

info@safar.partners

Safar Partners
One Broadway, 14th floor,
Cambridge, MA 02142